With the IPO window open, Aptinyx and Iterum look to get out before it closes.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180525/BLOGS11/180529912/2-drug-startups-to-go-public?utm_source=BLOGS11&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment